Lentine KL, et al. OPTN/SRTR 2020 Annual Data Report: Kidney. Am J Transplant 2022; 22 (Suppl 2):21–136. doi: 10.1111/ajt.16982
Reese PP, et al. Transplanting hepatitis C-positive kidneys. N Engl J Med 2015; 373:303–305. doi: 10.1056/NEJMp1505074
Durand CM, et al. Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to non-infected recipients: An open-labeled nonrandomized trial. Ann Intern Med 2018; 168:533–540. doi: 10.7326/M17-2871
Schaubel DE, et al. Five-year allograft survival for recipients of kidney transplants from hepatitis C virus-infected vs uninfected deceased donors in the direct-acting antiviral therapy era. JAMA 2022; 328:1102–1104. doi: 10.1001/jama.2022.12868
Delman AM, et al. Expanding the donor pool: First use of hepatitis B virus NAT-positive solid organ allografts into seronegative patients. Ann Surg 2021; 274:556–564. doi: 10.1097/SLA.0000000000005071
Carnemolla BT, et al. Use of hepatitis B-viremic donors in kidney transplant recipients: A single-center experience. Transplant Infect Dis 2022; 24:e13872. doi: 10.1111/tid.13872